• 1
  • 1
  • Favorite

Bank of America Raised to Outperform From Neutral by Baird

Dow Jones03-07

 

Ratings actions from Benzinga: https://www.benzinga.com/quote/BAC/analyst-ratings

 

(END) Dow Jones Newswires

 

Ratings actions from Benzinga: https://www.benzinga.com/quote/BAC/analyst-ratings

 

(END) Dow Jones Newswires

March 07, 2025 08:18 ET (13:18 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Cedric77
    ·03-07
    Bank of America's current stock performance is a mixed bag. On one hand, the company has a solid economic moat due to its huge scale and brand recognition, making it easy to attract deposits and sell loans ¹. This is reflected in its quarterly earnings per share of $0.82, exceeding analysts' expectations of $0.77 ². Additionally, Bank of America offers a quarterly dividend of $0.26 per share, translating to an annualized dividend yield of 2.25% ². On the other hand, the company's revenue missed Wall Street estimates by over $1.5 billion, and its net interest income declined 5% due to rising deposit costs ¹. Furthermore, Bank of America's net charge-offs soared 73% compared to Q4 2022, which could be a concern if the economy enters a recession ¹. Despite these challenges, many analysts rema
    Reply
    Report
errorbox banner

抱歉,当前请求异常(-1)

7x24

  • 07:50

    Europe's Stoxx 600 Reverses Earlier Gains, NOW Lower by 0.06% on Day

  • 07:50

    Samil Pharmaceutical: to Divest 4 Bln Won Worth of Own Shares

  • 07:47

    K+S SHARES EXTEND GAINS AND ARE ON TRACK FOR BEST DAY SINCE JANUARY, NOW UP 5.5%

  • 07:45

    Oncozenge Ab - Agreement Includes Milestone Payments of EUR 250,000 Upon Execution of Agreement and EUR 250,000 at Successful Completion of Planned Clinical Phase Iii Study

  • 07:45

    Oncozenge Ab - Receives Initial Milestone Payment From Molteni Farmaceutici

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial